BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
MSCI
MSCI Inc.
MSCI has the edge over BAC overall, supported by stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MSCI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MSCI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MSCI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
MSCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $652 | — |
| Current | 34x | $652 | — |
| Cheap | 36x | $680 | +4.4% |
| Fair | 44x | $824 | +27% |
| Expensive | 60x | $1,132 | +74% |
Historical ranges are pointers, not guarantees.
MSCI has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
MSCI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MSCI, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over MSCI on earnings, with more consistent year-over-year improvement.
MSCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $21.70 | +15% |
| Q3 2026 | $18.89 | +20% |
| Q2 2026 | $18.28 | +21% |
| Q1 2026 | $17.51 | +20% |
| Q4 2025 | $15.69 | +12% |
| Q3 2025 | $15.77 | +3.6% |
| Q2 2025 | $15.09 | +1.1% |
| Q1 2025 | $14.54 | -0.7% |
| Q4 2024 | $14.05 | -2.4% |
MSCI earned $18.89 per share over the past year, up 20% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MSCI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
MSCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $892M | +12% |
| Q2 2026 | $867M | +12% |
| Q1 2026 | $850.8M | +14% |
| Q4 2025 | $822.5M | +11% |
| Q3 2025 | $793.4M | +9.5% |
| Q2 2025 | $772.7M | +9.1% |
| Q1 2025 | $745.8M | +9.7% |
| Q4 2024 | $743.5M | +7.7% |
MSCI's revenue has grown year over year every quarter since late 2020: $892M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 56% | -0.1 points |
| Q2 2026 | 56% | +1.2 points |
| Q1 2026 | 54% | +3.2 points |
| Q4 2025 | 56% | +1.9 points |
| Q3 2025 | 56% | +1 points |
| Q2 2025 | 55% | +1 points |
| Q1 2025 | 51% | +0.6 points |
| Q4 2024 | 55% | +0.8 points |
MSCI has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
MSCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $422.7M | -5.1% |
| Q2 2026 | $359.8M | +11% |
| Q1 2026 | $304M | +4.7% |
| Q4 2025 | $488.7M | +17% |
| Q3 2025 | $445.5M | +7.4% |
| Q2 2025 | $324.7M | -4.7% |
| Q1 2025 | $290.2M | -1.9% |
| Q4 2024 | $416.4M | +8.1% |
MSCI has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MSCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -600K shares |
| 1 year | -5.6% | -4.3M shares |
| 3 years | -9.1% | -7.2M shares |
| 5 years | -13% | -11.3M shares |
| Available history | -15% | -13.2M shares |
MSCI has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $552.6M |
| Q2 2026 | $168.4M |
| Q1 2026 | $414.8M |
| Q4 2025 | $906.8M |
| Q3 2025 | $1.2B |
| Q2 2025 | $138.5M |
| Q1 2025 | $213.1M |
| Q4 2024 | $374M |
MSCI spent $2B buying back its own shares over the past year, up 4.7% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MSCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.3x | Elevated |
| Q4 2025 | 3.3x | Elevated |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.7x | Moderate |
MSCI has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MSCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.8 | Neutral |
| Stochastic | 83.3 | Overbought |
MSCI's weekly RSI is 65 (neutral) and its Stochastic is 83 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over MSCI on valuation relative to its sector.
MSCI PE vs Financial Services Sector
| Metric | MSCI | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 13x | 165% above |
| PE % | 11 | 63 | 52 pts below |
MSCI is trading at 34x earnings, a 165% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MSCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $594.1 | 9.7% above |
| 20 week MA | $583.0 | 12% above |
| 50 week MA | $575.8 | 13% above |
| 100 week MA | $571.3 | 14% above |
| 200 week MA | $551.7 | 18% above |
MSCI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
MSCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $260.0 | $432.5 | +66% |
| 2021 | $432.5 | $611.3 | +41% |
| 2022 | $611.3 | $463.8 | -24% |
| 2023 | $463.8 | $565.7 | +22% |
| 2024 | $565.7 | $609.6 | +7.8% |
| 2025 | $609.6 | $585.0 | -4% |
| 2026 YTD | $585.0 | $651.5 | +11% |
MSCI has the edge over BAC on returns for 2026, with the stronger performance.